TP53 and Hepatic fibrosis: For example, resveratrol (i) inhibits liver steatosis [22]; (ii) inhibits the proliferation of rat HSCs [23]; (iii) inhibits liver p53 gene expression in paracetamol-mediated acute hepatic injury in rats [24]; (iv) inhibits lipopolysacharride-induced inflammation and hepatic fibrosis in mice [25]; (v) suppresses cholestasis-induced liver injury and fibrosis [26]; and (vi) reduces miR-155 induced cardiac hypertrophy [27].